NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.7500
+0.0100 (1.35%)
Oct 23, 2025, 3:40 PM EDT
1.35%
Market Cap61.88M
Revenue (ttm)n/a
Net Income (ttm)-8.62M
Shares Out82.51M
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume123,960
Average Volume76,741
Open0.7600
Previous Close0.7400
Day's Range0.7000 - 0.7600
52-Week Range0.5300 - 1.1400
Beta0.21
RSI32.97
Earnings DateNov 28, 2025

About NurExone Biologic

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other ne... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.